About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Endocrinology
General Surgery
Hematology
Nephrology
Neurosurgery
Oncology
Oral Maxillofacial
Orthopaedics
Pediatrics
Plastic Surgery
Podiatry
Primary Care
Pulmonology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
Next Questions in Myeloma: Biology, smoldering myeloma, high-risk, MRD, and how to salvage therapy
By
Society of Hematologic Oncology Sixth Annual Meeting
FEATURING
Sundar Jagannath
10/2018
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
City of Hope
How the Experts Treat Hematologic Malignancies
Thu, Mar 21, 2019
Indy Hematology Review
16th Annual Indy Hematology Review
Sat, Mar 9, 2019
19:48
Gareth J Morgan
Contemporary Design of MM Treatment: Developing New Therapeutic Endpoint...
17:02
Ajai Chari
Diagnosing Smoldering Multiple Myeloma
17:46
Dana-Farber Cancer Institute
Relapse Refractory Myeloma and Novel Treatments
Feat.
N. Raje
09:49
Nina Shah
Maximizing the Initial Gains in Myeloma Therapy: Consolidation and Maint...
13:25
Shaji Kumar
Evolving Concepts in the Diagnosis and Risk Stratification of Myeloma
19:40
Peter Voorhees
Approach to the Patient with Refractory & Multiple Relapsed Multiple Mye...
12:31
Indy Hematology Review
What's New in Immunotherapy and Genomics in Multiple Myeloma?
Feat.
K. Anderson
17:02
Thomas Martin
Novel Clinical Trials for Smoldering Multiple Myeloma in 2018
15:10
Ajay Nooka
Early Relapse: Choosing Among Different Second Line Regimens in Myeloma
15:30
Parameswaran Hari
Refractory and Relapsing Myeloma - When to Treat and Options Available
14:42
Society of Hematologic Oncology Sixth Annual Meeting
What Will The Future Hold for Myeloma Treatment CARTs vs BiTES?
Feat.
R. Orlowski
12:43
Bart Barlogie
Clinical Manifestations & Diagnostic Work Up of Myeloma
06:22
Parameswaran Hari
Treating Refractory & Relapsing Myeloma: Current Trends and Recommendati...
53:45
Kenneth Anderson
Update on Diagnosis and Treatment of Plasma Cell Dyscrasias
19:28
C. Ola Landgren
Should Smoldering Myeloma Be Treated?
09:00
Maria-Victoria Mateos
FDA Approves Once-Weekly Carfilzomib Regimen for Myeloma
16:58
Nina Shah
The Future of CAR T Therapies in Myeloma in 2018
11:50
C. Ola Landgren
Aiming for Minimal Residual Disease Negative Status in all Myeloma Patients
18:43
City of Hope
The Promise of Immunotherapy and Newer Agents in Multiple Myeloma
Feat.
A. Krishnan
15:05
Gareth J Morgan
Contemporary Design of MM Treatment : Complexity of Myeloma Biology, Add...
